From Data Wrangling to Decision-Making

Catch the Full Episode

On the last episode of The End Talks, Biorce CEO Pedro Coelho sits down with Adam Taylor, currently Director of Decision Science for Clinical Operations at GSK, with more than 22 years of experience across the pharmaceutical industry.

Together, they explore:

• Why clinical teams still lose most of their time to operational inefficiencies

• Why protocols, sites, and patient targeting are still struggling to deliver efficiently at scale

• How personalized medicine is reshaping modern clinical trials

• Why trust in AI depends on transparency, not black-box outputs

This is a conversation about the key changes needed to remove operational friction so clinical teams can focus on patients, sites, and better execution.

Together, they explore:

• Why clinical teams still lose most of their time to operational inefficiencies

• Why protocols, sites, and patient targeting are still struggling to deliver efficiently at scale

• How personalized medicine is reshaping modern clinical trials

• Why trust in AI depends on transparency, not black-box outputs

This is a conversation about the key changes needed to remove operational friction so clinical teams can focus on patients, sites, and better execution.